0000899243-17-023946.txt : 20171010
0000899243-17-023946.hdr.sgml : 20171009
20171010161137
ACCESSION NUMBER: 0000899243-17-023946
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171009
FILED AS OF DATE: 20171010
DATE AS OF CHANGE: 20171010
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gengos Andrew
CENTRAL INDEX KEY: 0001563623
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37566
FILM NUMBER: 171130617
MAIL ADDRESS:
STREET 1: 21900 BURBANK BOULEVARD
STREET 2: 3RD FLOOR
CITY: WOODLAND HILLS
STATE: CA
ZIP: 91367
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNLOGIC, INC.
CENTRAL INDEX KEY: 0001527599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261824804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SIDNEY STREET
STREET 2: SUITE 320
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-401-9975
MAIL ADDRESS:
STREET 1: 200 SIDNEY STREET
STREET 2: SUITE 320
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Mirna Therapeutics, Inc.
DATE OF NAME CHANGE: 20110809
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2017-10-09
1
0001527599
SYNLOGIC, INC.
SYBX
0001563623
Gengos Andrew
C/O SYNLOGIC, INC.
200 SIDNEY STREET, SUITE 320
CAMBRIDGE
MA
02139
0
1
0
0
See Remarks
Chief Operating Officer and Head of Corporate Development
/s/ William J. Bussiere, Jr., Attorney-in-fact
2017-10-10